Karakitsos D N, Patrianakos A P, Paraskevopoulos A, Parthenakis F I, Tzenakis N, Fourtounas C, Daphnis E K, Vardas P E
Department of Nephrology, Heraklion University Hospital, Crete - Greece.
Int J Artif Organs. 2006 Jun;29(6):564-72. doi: 10.1177/039139880602900604.
Hemodialysis patients experience a variety of hemodynamic abnormalities that contribute to cardiovascular disease mortality which is the leading cause of death in these patients. Impedance cardiography has been utilized in order to monitor cardiac hemodynamics with lower cost and inconvenience, but it has not been appropriately validated in the hemodialysis population.
We repeatedly used impedance cardiography to assess short- (48 hours) and long-term (15 days) reproducibility of cardiac output measurements and we compared baseline impedance cardiography measurements with echocardiographic measurements.
We studied 109 stable hemodialysis patients, aged 59.70 +/- 11.97 years being on hemodialysis for 67.59 +/- 40.15 months, on a non-dialysis day. Cardiac output was obtained with the BioZ impedance cardiography system (Cardiodynamics, San Diego, Ca, USA). Baseline echocardiography was performed using a Hewlett-Packard Sonos 2500 (Andover, Mass., USA).
The values of impedance cardiography derived cardiac output were 5.28 +/- 0.79, 5.27 +/- 0.75 and 5.25 +/- 0.74 l/min at baseline (107 patients), 48 hours (107 patients) and 15 days (98 patients) respectively, showing high reproducibility. Bland and Altman analysis estimated that bias at 48 hours and at 15 days were: -0.013 (95% confidence intervals = -0.045 to 0.019) and 0.028, (95% confidence intervals = -0.044 to 0.101), respectively. In addition baseline impedance cardiography derived cardiac output was significantly correlated with the echocardiographic derived cardiac output (r = 0.9, p < 0.0001).
Impedance cardiography is a simple non invasive technique for cardiac output estimation in hemodialysis patients which has high reproducibility when performed under controlled conditions, and is closely correlated with echocardiographic measurements of cardiac output.
血液透析患者会出现多种血流动力学异常,这些异常会导致心血管疾病死亡,而心血管疾病死亡是这些患者的主要死因。为了以更低的成本和更少的不便来监测心脏血流动力学,已采用了阻抗心动描记法,但它在血液透析人群中尚未得到充分验证。
我们反复使用阻抗心动描记法来评估心输出量测量的短期(48小时)和长期(15天)可重复性,并将基线阻抗心动描记法测量结果与超声心动图测量结果进行比较。
我们研究了109例稳定的血液透析患者,年龄为59.70±11.97岁,血液透析时间为67.59±40.15个月,研究在非透析日进行。使用BioZ阻抗心动描记系统(美国加利福尼亚州圣地亚哥的Cardiodynamics公司)获取心输出量。使用惠普Sonos 2500(美国马萨诸塞州安多弗)进行基线超声心动图检查。
在基线(107例患者)、48小时(107例患者)和15天(98例患者)时,阻抗心动描记法得出的心输出量值分别为5.28±0.79、5.27±0.75和5.25±0.74升/分钟,显示出高可重复性。Bland和Altman分析估计,48小时和15天时的偏差分别为:-0.013(95%置信区间=-0.045至0.019)和0.028(95%置信区间=-0.044至0.101)。此外,基线阻抗心动描记法得出的心输出量与超声心动图得出的心输出量显著相关(r=0.9,p<0.0001)。
阻抗心动描记法是一种用于估计血液透析患者心输出量的简单非侵入性技术,在受控条件下进行时具有高可重复性,并且与心输出量的超声心动图测量密切相关。